Inhibrx is transitioning from a platform to a clinical-stage biotech, with ozekibart and INBRX-106 as key value drivers.

Cloud Inventory®, a leader in mobile-first inventory solutions, has launched the newest release of its Mobile Enterprise ...

Relying on a high salary or a hot stock is a dangerous trap. Why the most secure people plan for sudden crisis.

SAN DIEGO, CA / ACCESS Newswire / July 10, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or ...

GoldArc Resources is moving closer to production at Mt Stirling, with grade control drilling approaching completion and new ...

Molson Coors is facing a challenging operating environment created by a double whammy of declining volumes and rising input ...

Sen. Bernie Sanders introduced legislation that would confiscate 50% of the ownership of America's most successful artificial ...

Palantir's U.S. revenue hit $1.3B in Q1 2026 — a 104% jump. We break down what's driving the growth, why the valuation debate ...

The traditional pipeline model treats provisioning and configuration as adjacent stages. A more mature model treats them as ...

Six months after Naveen Jain quit Microsoft and convinced his wife to give him time to prove himself as an entrepreneur, he went on to found InfoSpace, which expanded from a six-person startup into ...

If most of your net worth is tied up in your business, an ESOP could be a way out. But before you consider it, understand the ...

JGBs have been selling off amid policy normalization and concerns over Tokyo's spending plans, but experts say that they ...